Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.

Original languageEnglish (US)
Pages (from-to)496-501
Number of pages6
JournalCardiovascular and Interventional Radiology
Volume40
Issue number4
DOIs
StatePublished - Apr 1 2017

Keywords

  • Colon cancer
  • Drug elutting beads
  • Transarterial chemoembolization (TACE)

Fingerprint Dive into the research topics of 'Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease'. Together they form a unique fingerprint.

Cite this